Learning Objectives:

Recognize unmet needs in the current clinical landscape of NSCLC treatments and biomarkers
Understand the utility of stable isotope tracing to measure tumor metabolism
Understand the therapeutic potential of targeting metabolic adaptations in NSCLC
Session date: 
11/18/2024 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Robert Cameron